News Search

View the CUIMC Update, a weekly e-newsletter featuring medical center news and the accomplishments of our faculty, staff, and trainees.

Based on Columbia research, an experimental drug for a rare type of ALS is being tested in a phase 3 clinical trial after a new study found that the drug lowered levels of a toxic protein.

Just a single type of neuron controls the complex patterns of walking, a surprising finding that may lead to new therapeutic approaches for people with spinal cord injuries.

New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.